ARCHIVES

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

This article is from The Cancer Letter archive.

Vol. 13 No. 15 | April 10, 1987

Download PDF Visit The Full Archive

Related Articles

Trials Approved by NCI CTEP For the Month of January

January 27, 2012

In Brief: Cancer Panel to Meet Sept. 30 In Boston; House Passes Money Bill, With 41.347 Billion For NCI

August 15, 1986

NCI’s New Divisional Structure In Place, Next Step Is Review Of Labs, Branches

October 13, 1995

DES Exposure Studies Below Payline; NCI Considers Contracts

March 6, 1992

The Emergence Of The National Dialogue On Cancer, 2000-2002: Special Report

August 8, 2003

In Brief: George Vande Woude Of NCI Named PI for Litton Bionetics Basic Research Contract At Frederick

September 23, 1983